Filtered By:
Vaccination: Vaccines
Countries: India Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3297 results found since Jan 2013.
Case report on meningoenceplapathy in an Indian patient post CoViD vaccination
Bioinformation. 2023 Jan 31;19(1):117-119. doi: 10.6026/97320630019117. eCollection 2023.ABSTRACTThe SARS-COV-2 infection-related severe illness is prevented by vaccinations. Therefore, it is relevant to report a case of post vaccine meningoencephalitis in a 30 year old male Indian patient, who presented with weakness in all the extremities, episodes of loose stool, fever, vomiting, tachypnea and loss of consciousness immediately following the 2nd dose of the COVID vaccination (COVAXIN).PMID:37720286 | PMC:PMC10504505 | DOI:10.6026/97320630019117
Source: Bioinformation - September 18, 2023 Category: Bioinformatics Authors: Raj Kamal Choudhry Amrendra Kumar Singh Kumar Sourav Anjum Pervez Abilesh Kumar Subham Kumar Source Type: research
Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics
Immunology. 2023 Sep 15. doi: 10.1111/imm.13695. Online ahead of print.ABSTRACTNipah virus (NiV) causes severe encephalitis in humans. Three NiV strains NiV-Malaysia (NiVM ), NiV Bangladesh (NiVB ), and NiV India (NiVI reported in 2019) have been circulating in South-Asian nations. Sporadic outbreak observed in South-East Asian countries but human to human transmission raises the concern about its pandemic potential. The presence of the viral genome in reservoir bats has further confirmed that NiV has spread to the African and Australian continents. NiV research activities have gained momentum to achieve specific preparedn...
Source: Immunology - September 15, 2023 Category: Allergy & Immunology Authors: Gayatree Mishra Vishal Prajapat Debasis Nayak Source Type: research
Infections due to Salmonella sp. in children with chronic granulomatous disease: Our experience from North India
Clin Immunol. 2023 Sep 11:109769. doi: 10.1016/j.clim.2023.109769. Online ahead of print.ABSTRACTInfections with non-typhoidal Salmonella sp. have been documented in children with chronic granulomatous disease (CGD), but the prevalence of salmonella infection in children with CGD in underdeveloped countries is unknown. We assessed the clinical profiles of CGD patients diagnosed at our tertiary care centre in north India and had Salmonella sp.infections. We found three patients with Salmonella sp. bloodstream infections (2-proven, 1-probable) among the 99 CGD patients. After receiving cotrimoxazole prophylaxis following a C...
Source: Clinical Immunology - September 13, 2023 Category: Allergy & Immunology Authors: Suprit Basu Pandiarajan Vignesh K Prithiviraj Pallavi L Nadig Aravind Sekar Amit Rawat Source Type: research
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate
In this study, we investigated the protective efficacy of an inactivated PRRS virus vaccine candidate and evaluated the differences in PRRSV specific anamnestic response in piglets when challenged with live PRRSV at two different intervals post-immunization. Six-week-old piglets were immunized intramuscularly with an inactivated, Montanide ISA-206 adjuvanted Indian PRRSV isolate, followed by a booster dose at 21 days post-immunization. Homologous live PRRS virus challenge was done on 60 and 180 days post-booster (dpb). We assessed humoral and cell-mediated immune responses at various intervals post-immunization and after c...
Source: Vaccine - September 9, 2023 Category: Allergy & Immunology Authors: Megha Katare Pandey Katherukamem Rajukumar Dhanapal Senthilkumar Subbiah Kombiah Fateh Singh Govindarajulu Venkatesh Manoj Kumar Sangeeta Shrivas Deepali Shrivastava Vijendra Pal Singh Aniket Sanyal Source Type: research
An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses - A meeting report
This report summarises the discussions and lessons learned on two topics: an update on one-dose HPV vaccination studies and humoral immune responses upon HPV vaccination. Long-term follow-up studies from Costa Rica (eleven years) and India (ten years) report stable levels of antibodies after a single HPV vaccination. High vaccine effectiveness against incident persistent HPV 16/18 infection was seen in India (95.4%, 85.0-99.9) ten years postvaccination and in Kenya (97.5%, 81.7-99.7) eighteen months postvaccination, an important observation in a setting with a higher HPV prevalence. The potential impact of HPV vaccination ...
Source: Cancer Control - September 8, 2023 Category: Cancer & Oncology Authors: Dur-E-Nayab Waheed F Ricardo Burdier Carina Eklund Iacopo Baussano Filipe Cola ço Mariz Laura T éblick Nelly Mugo Deborah Watson-Jones Margaret Stanley Marc Baay Alex Vorsters Source Type: research
Determinants of post discharge mortality among hospitalized COVID-19 patients: Nested matched case-control analyses from the National Clinical Registry for COVID-19
CONCLUSIONS: : Prior vaccination protects against post discharge mortality till one year in hospitalized COVID-19 patients. PCC may have long term deleterious effects, including mortality, for which further research is warranted.PMID:37675689 | DOI:10.4103/ijmr.ijmr_973_23
Source: Indian J Med Res - September 7, 2023 Category: Research Authors: Gunjan Kumar Arunansu Talukdar Alka Turuk Ashish Bhalla Subhasis Mukherjee Pankaj Bhardwaj Tarun Bhatnagar Aparna Mukherjee Source Type: research
